Bulk Pharmaceutical API Sources for carteolol hydrochloride

Bulk Pharmaceutical API Sources for carteolol hydrochloride

Vendor	Vendor Homepage	Vendor Sku	API Url
Finetech Industry Limited		FT-0640026
AbaChemScene		CS-2955
MedChemexpress MCE		HY-17495A
Molport		MolPort-006-129-555

Bulk Active Pharmaceutical Ingredient (API) Sources for: CARTEOLOL HYDROCHLORIDE

Last updated: July 29, 2025

Introduction

Carteolol hydrochloride is a non-selective beta-adrenergic receptor blocker primarily used in ophthalmology to reduce intraocular pressure in glaucoma and ocular hypertension. As an essential pharmaceutical ingredient, its sourcing quality and reliability are pivotal for manufacturing efficacy, compliance, and patent management. This analysis provides a comprehensive overview of bulk API sources for carteolol hydrochloride, focusing on manufacturer profiles, geographic distribution, quality standards, and supply chain considerations.

Global API Manufacturing Landscape for Carteolol Hydrochloride

The production of carteolol hydrochloride is concentrated among a select group of pharmaceutical API manufacturers, predominantly based in India, China, and Europe. These regions host facilities compliant with Good Manufacturing Practices (GMP) and hold certifications from regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and others.

Leading API Manufacturers

1. Taj Pharmaceuticals Ltd. (India)
   As a significant supplier of beta-blocker APIs, Taj Pharmaceuticals has established a reputation for high-quality manufacturing standards. Their facilities are GMP-certified, with certifications such as WHO-GMP, ensuring compliance with international quality benchmarks. Taj supplies carteolol hydrochloride to global markets, emphasizing cost-competitiveness and reliable capacity.

2. Sun Pharmaceutical Industries Ltd. (India)
   Sun Pharma, an industry giant, offers a robust pipeline of ophthalmic APIs, including carteolol hydrochloride, sourced from their extensive manufacturing network. Their API plants adhere to strict quality standards, with multiple certifications such as US FDA approval and ISO certifications.

3. Sino Biopharmaceutical Ltd. (China)
   Chinese pharmaceutical companies like Sino Biopharmaceutical supply bulk carteolol hydrochloride at competitive pricing, leveraging China’s extensive API manufacturing infrastructure. Their facilities comply with CN-GMP standards, with increasing adoption of international recognition to expand export opportunities.

4. Mundipharma/AbbVie (Europe)
   While primarily known for finished formulations, some European API manufacturers provide high-purity carteolol hydrochloride. These suppliers often cater to partnerships or direct API procurement for branded or generic ophthalmic products in regulated markets.

5. Other Notable API Suppliers

   • Wuhan Perfect Sino Pharm Co., Ltd. (China): Certified facilities producing carteolol hydrochloride for bulk supply under GMP standards.
   • Hubei Biocause Pharmaceutical Co. (China): Offers competitive pricing with quality certifications aligned with international standards.

Quality and Regulatory Considerations

For procurement purposes, it is critical to prioritize API suppliers with GMP certification, ISO quality certifications, and regulatory approvals such as FDA or EMA authorization. Certificates of Analysis (CoA), stability data, and batch consistency are vital to ensuring regulatory compliance and maintaining product quality. Manufacturers who participate in DMF (Drug Master File) filings with major regulatory agencies facilitate transparency and streamline approval processes.

Supply Chain Dynamics and Risks

Dependence on a limited pool of suppliers exposes manufacturers to supply chain risks, including manufacturing disruptions, geopolitical issues, and regulatory sanctions. For example, recent global supply chain disruptions, notably during the COVID-19 pandemic, highlighted the importance of diversifying API sources. Therefore, establishing relationships with multiple accredited suppliers—both from India and China—and considering regional suppliers in Europe or North America, can mitigate risks.

Emerging Trends in API Sourcing

• Vertical Integration: Some pharmaceutical companies are acquiring or developing in-house API manufacturing units for carteolol hydrochloride, ensuring supply security and proprietary control.
• Regulatory Harmonization: Increased focus on compliance standards like ICH Q7 for Good Manufacturing Practice of Active Pharmaceutical Ingredients improves supplier reliability.
• Sustainability and Green Chemistry: Growing demand for environmentally sustainable sourcing influences future API supplier selection criteria, with suppliers investing in eco-friendly manufacturing processes.

Market Opportunities and Challenges

The demand for ophthalmic beta-blockers like carteolol hydrochloride is stable, driven by glaucoma prevalence and ophthalmic therapeutics expansion. However, sourcing challenges include regulatory hurdles, supply chain disruptions, and price fluctuations. Manufacturers seeking competitive, high-quality APIs should weigh supplier certifications, capacity, historical reliability, and compliance with evolving international standards.

---

Key Takeaways

• Diverse Supplier Base: Leading API sources include Taj Pharmaceuticals, Sun Pharma, Chinese manufacturers like Sino Biopharmaceutical, and European suppliers, offering varied options based on quality and cost.
• Regulatory Compliance: Prioritize suppliers with GMP certification and regulatory approvals (FDA, EMA), along with comprehensive documentation for quality assurance.
• Supply Chain Risk Management: Diversify sources and establish strategic partnerships across regions to minimize disruptions.
• Emerging Standards: Follow trends toward sustainability and stricter quality standards, ensuring API suppliers adapt to market and regulatory expectations.
• Informed Procurement: Employ rigorous due diligence, including audit and validation, to ensure the quality, purity, and consistency of bulk API sources.

---

FAQs

1. Are there any fully integrated manufacturers for carteolol hydrochloride to consider?
Yes, some Indian and Chinese API manufacturers are moving towards vertical integration, controlling entire production processes to enhance quality and supply security.

2. What certifications should I verify when sourcing carteolol hydrochloride API?
Prioritize suppliers with GMP, ISO 9001/ISO 14001, and, where applicable, FDA or EMA approvals, along with comprehensive Certificates of Analysis and stability data.

3. How can supply chain disruptions impact APIs like carteolol hydrochloride?
Disruptions can lead to shortages, delays, and price volatility. Diversifying suppliers, regional sourcing, and maintaining safety stock are recommended mitigation strategies.

4. Is there a trend toward sustainable or green manufacturing in API sourcing?
Yes. Regulatory agencies and global manufacturers increasingly demand environmentally friendly processes, with suppliers investing in green chemistry and sustainable sourcing practices.

5. Are regional regulations affecting API sourcing options for carteolol hydrochloride?
Regional regulations influence supplier eligibility. Companies should stay aligned with local and international standards to facilitate approval and ensure compliance across markets.

---

References

1. U.S. Food and Drug Administration (FDA) – API Manufacturer Database.
2. World Health Organization (WHO) – GMP Guidelines for Active Pharmaceutical Ingredients.
3. European Medicines Agency (EMA) – Quality standards for APIs.
4. Industry reports on global API manufacturing capacity and supply chain trends.
5. Company disclosures and certification documents from listed API manufacturers.